Gene-based Assays


Genetics Squared Changes Name To Everist Genomics, Names New CEO

Ann Arbor-based Genetics Squared, a company developing gene-based assays for the prediction of cancer recurrence, announced that it will change its corporate name to Everist Genomics and has appointed Prasad Sunkara as its new president and CEO, effective immediately. Its founder and former CEO will continue as CTO.



Get every new post delivered to your Inbox.

Join 3,814 other followers